y_F8W!IBIR uFe[^eJ3L'so~T*zpPRGi/(8MN;WiVOr!+(_i+q'XbɯQrV~͜I;y8d5Gr}vY &hN|: 95<k|.1JFW`v0I4> >r:aޗdu0K8H?X*FRح Va2ON~wڲfVfe>vF-l-JX&sߘ h|m-DZnTުr>|}4Oo+׾s oˮ~|Uξz{8?zs> cf1?'ћŬLKm<=:?-(ͧk[PWفFQ7j{QnȂ)9 5.guo^f4Y>͎ogI{Q o󣧹=z{dGGǧ(w{Um}ߝ"`_Sl=Uv/arJ=O׾0~t:yZAĝ `kc*`hlקcͣ܎FӃE~duM͙Z:k;~xzxjo⷟Z9C뢬Tٮf+HսZrSs `y cd+0N0Dv.>-_vܑ@1?/WI=-\Nn8%C G~^q{egŬ.j73 R9FU=:` 8 |izu*  ̕ ^JK\%~Zo"?Ujg{{Λa'orz O,D92hiڳ[x*gosU6VZf.NePD|wi\ζ{뷋IWщN}`pr@қ~{?*sT8_MI**ur1ovim˧&s{b]-U+m/At_Aet̯7ɞI>Vje@ymt7[w={j+B~/7utD-GKr&߿o2SiZWl/ޞF\YnuNus8?ܪG壋z̕{_Ej1MΫ *+d?Εc󯎎ܹ_?*r S-n~^URo|biZ>Jm7r ILR[p~`ςkZvKgaEtl7rpNjjOJpgmu2yW[vPvʈ_}soqE "(%X/ӏ`s˫,6 \?~Sq+ f7<*@'߿՞ηO3)Ukcy @-*tN*Z\ǹU#Tpg`T\):??o SΣ(_]8qz]njdA>E\z09i-OO|r>HwxEq A^ׯT@9Zv3 %|zp#}ܒ5=Wo\v !/2N΀u|]<[9sC"<.{gK~.|z}^\=|VgSXŋ1;TtqQ ٙ|'l}|ʞV ~]C:T_~3]z2טOߨP$x˾k>xi/|ykޞ'5vί)u;8j7;9d]䌐7QRn//9m zl8Ig͖%$#.,n*^Rp`:HӽE1`w ܱzav`U[> k{HBp"(|iE9 KjteTU0v[p{g H!0xYNR$@҅# x*{`h#3ts*N ѥq}*A(tsIiZ9x{x*:xcr9-'jRlzTX68KvrlOKj =yFyI$?EAm[t:o>#D9nOE9 d/NsY ȏBQ~ppH>#/L>;Ǝ$i̟_ v-{U|f3r ~wdU"BFp6TL!<d?dΠAYS7OTRސo6 MK@ ŗ77[T/8CnF]V ZD(ri).#AGQG`1}OU]?{H n 0򘼁ɳ[^?U|KAlEK12q;C̡asR-l/5ٛ_yz=>FwU0)A9-!\)"_3 @AW|NE-xIX-dISh~F)&obyھ=WJc*08_ɹ\2ϾFmI J3ͫv@H` sh%trB oR]_]g n?Py]uz)N''xV<9? Pdǀ&k/udcd;\ n>3܊k>r +_'Sd=Y2_Llz0x?``@*g] '7"D0 `Gjp*X|`yg/_w<\#ોpJ@+ݷ{+ii^}BCJp&c@wWnp՝PxZ#GkAF&rA0lbh ݿ+?1qlU&ZF)Ih} ћ&V.WR1.8=MDt3"h'*{upM:{ݟF!Ww6 >vAUR<[;Adh4']$i`!XȿBfa!@fV}WNEFciI5:Eh4b06":\C M5dmze ʼnPDhؽ^FקHyN.D[| +4*:PՓY(ʉ+kgBkf? f&@#SohQ+@!&;|QZ77׮=p71.c~;>$ˎҽy=C*{/@;s<)؃6 @6H[*P]WO{GQ;LW/rG{ܳ^EoGKȥZ"&~NlZ}D]5B/OyxEB3,<]lrf@Xw.?}P! 2! ~H#@mGz. TbwE, &[N@|pD萀69y wq䎏O6ZEtv{ɄNLcXLjfhyhnbMםb4BxvJAdϿÿUG봐82zUƺMA#` xj1T沦~%({XBpHPOdx5g 61t6ӳkBŬr>nwg?!; ïH|9 ۝^oжE*;jq%Z5Hj{:!doژxxc$\0SjR.y+ $:{} 8_p_~OLt\C<{tɎJw"q?rhK QET^`&q)B7&;l>,Fh _tgO__*/ aw /@qΪB.X԰+ۛazQvpQ{߿a|W~8VnŇὪN/Ztu0|zW\Y_m654-ۣ{_図Hb?V?|mU?֝|{~&ؿ*zZYož},~{Wm5[;6~rt}._ڞZirrjٸpy䞽} Uox]kÇssE:8bn+Iz9 ѧpuw/ pUɺnPg6}'XK.\O}z}wtq7[Z90rośꃽuOΗSQ7//+o?m[Mon6oVi;n  eY=X~q/=ݷ3ك5WzOc/89~KE/fk߿;6jq'՗G3;8wlA|gWp>W?R>zqt}[=}_[c9"~+W߾_97wg??^~|^_MJ vUپm|E~տʗ}ϳǫG_Jo{|5{|km:<\)`EyFԣOwOGWvZ}SnoݍlWIz<|)aћǻ4gj{-(o\q *077mZ~,t]*nׇ_foi%~Zۧ]vtUl.~ɇOڋۻ7՛?G1mC#^t;wʷֱwۧ7P5jϽhiܳ6j|V/[In/>Mq[&~\衳|Zԃw"9.nկ^}Qϗշ-杷VE:r/{7˳u]{gEzTV헶l:zǯW~ 旯vv'bw&7CKu~=&fKe|mr4_mCcUk?ų73k0< W;ʯVZC|Tz ~Ti,8SN+v[uY_Xnrٻ.;C'/ct0<-ˉ57_o?_UlmcYAz===ǫ3eok}ro"?_?}'nWg:ܿ{koZpUYݷ/JruNK|q/?<y8rLf+{AwuYQ[w>Zw{n{ݙP|Ov[SKex)WxZ?6o?ַG}Syvj>ߎ6oWWq;*^\Ϗcc8ԇzx΂4xj{>o+{ʧm` ?]hЯ/{?U!y鍣*mK{&vv~{muߧ{ZjqAOYK=>|׺W/żuX= N|}+_7o}Sc]{}RY/{O 8y8|%W+[ $=pnKou`?w7nӧquY>:WoVw{WCkxANB?{HY}l 7W=X}+g73q_ďoë\yqqO G{?5*3rQ9M{u^~ݻ}\6.=m_4NnR^ ó헛Ż7O{3[OWo7wgύ/w۫Wipr|pE~;{s.c_}~\eo?] O?jLhzuxvjx}*+pmoӷU{cxt:o~v]Cwjoe 8u[^CcM~3W?U>?\JgCݫmn./o\|V?=<^~9]ꀨU+߮MէoK@Au6[༻f>iL`U{a{x{V^=o^=}XT>k~j-X_Zn.,axXԧ:#>}7ه=|Z}Rսq[\:7Wo~ڞVw˳٧ۏ_/|wpuzz^||Tm8F?˧j~px:~b?]|?&^)QWd ,L3iK\Z Y2 ,|ֻ `hJ l5$ۯM>0pѫ8̣\Q APɌ)q#MHJ  @˶xzqGa m92`F- ge˄H4f5SVԒekii˴3P.es(d" ?L׿q=7=:-tl؞}4|(/:@~;*qlOrϣBeB鞠Ɣtﯗ $PT]=%<gL?~;:]0TbksQ>ϯa-v.O]4?lC}Nsc?nՑL/m{W;msS=0=D r-c3M Bu~ˎR2߻=87XSόP ?ðsB }oowS2 [owq{% f@( 'comB/1EbB?yv SEEs;cn|\Lg8"ĦppEEj]\?yvǼny+Z(d_~abwb>{cT6ձ}K_[Հ/kkwܢc!1נ9 9/ `}.oE_ ޖ`dz:RJiTTϏYwAY.Bг!ja"0ʂPEqp Rvg=0jѻ^sK= my;u rWQkox3X9g'2BK]N!2|""}~c ̅%E3 =/1f">v؇Yp#v120 @5A5~8Er,BlW@fZDmKCk`8 /#'ˑ j0W qZ޸r<Ǒx}cuoλ9JD?E77^0~!j qX}̌w(|ƊV_Avc6Ev}E_u6 D^;]4]侢Dα<=^Id6]l>Q!%o/8y̮ |5Uk}ϟu`s LJ / lx%r8 ,|NѤZoNNI-zoq_o^w?eՐ sЀ' 0 Cq)ń}l F\]j@AFFɯkAw%TyOW O~Qw(n%hȂT|}y?ŗ&||<׿qz?^8|ࣻE ||>; U>}Ÿk߿r>,|h6n緯W|l_݁O^o|ʼDrGt4o +8w+l W?W :&8J8'jr>>s8Ygq™ ?Yp/>{ Ww|^tq2h'<j%56F ,&UU|ܨ7F%A-~[{W 8)֪fOGDj8* !ҠF5Y:u 5 2{MO>h:Z aP\CYQv'F|֩5 F9[ä" iG4*Ie}Bݑ3cuDvVs{Coa-FӖ.2_-baXaLсy!Y=]a$4ge꧚tfwm`n_ћ^0o.X8´5&NP,eg n0zO:#'+aVINЏdM^kcvm3u{nIsx_'N7aU u4=S[ڬƖR(`(2@P[Qe,} }s .Y *VyhAHn\2vm:#W]qB3m'd'Uķ3'B36A߶釛w?ytzS+ ExpkTǞ錻+>mZ&Ϟ[=,]05xrhˠ3<4ؤL~<]BLR5.ӑڲ,30玛-jhOcctr/${2Ǭ T [;T|:(X&f6?N/б!`L6I,(Q2C8ڰЕNhR(obl2^#k6 ;'ĴWZ/p#SWi8{t #ɐT|UȯZ-RL bY-*m"(QU]F]]ukCTL~F:77<% `Q7y+%~䍂fV "(A*$X5 2*oNA޹IS^Փ`P{gZV]6W>,iKi< nݵjYV:;HH8)d73&E0:N{Bpr>y4~4 t\ll-4wVR`|UjBֳdCȹbIN#;hn;"|l[ ,>%H%gp-tK{hk0Epr!iű>Fˎ@F NvUŬ$rݳG-8C|ЦFX-zn-^ƫ=1` <%pr~kvVM==Oǩ9uBT8_+m`4"y`.uUBqX:s!DqzQIX|&AS8Gu7{j0--i<+?_aіet#%a܃@y#c[!a(1QțD.W>9߽6d1*lS+voh:yvlS'!= Ax[dDdۈ;XLܑ&\8FkvfH]dzg O8dwJ걇c&^[dr񡘋LT\S}R[mSo8m>7r.zQC-6`>Qﵓ ŪeHFvrs(a]Ҕ[ٲ LVݰ?okxb 7wԅMPɁGFPͯDw@.Xp򓵿= oBMȞd ٺ >Lq$~LD0`*'xo?SpNdM+tiWl8ZtpsZmK\LCqsMKA7,,::5J 9OG' ܖZܰ~QBUĤDEѦYwm;h ݟ7PÃd^m~0Bюapo1 ӑVeHPusKf[vF1Scľ;p0c<ΉbMǩd/[֔vMt5C"BjwgLIZ,3^ED#q/u:H!S+!J/M7Nn顚 wPpހ"O3jLZ5[PoxٵzKhhk"c8 š7퉝̭b`|rRt^+s(i5j?T`O~&vvԾ1|1:X!œߘHfvz h ppc2c-) ۂ3[qgRAr\([8TaAazBNFq.7/`y\ q.s9ugvyE&l@![gقP:;̔a%ٚHSڛ_@\k8G#Sr\qJќKF MHT.2ܓ sE^-W =|vrײ&h7NKV7c<=FmOzN4[6USYFjeݷ;3YtZP׆ Rn䭠nr{t|OǭIbŠ[?D|#O8i .|M0f`p< yC%F;jUo  E9 !VItCnC7m%ê]\+1Axu2=e=COq9C9/EOq! 2zV]/ SWq tgt4 bć@tafꇫH9 YSӰ@/A"(l- ⻄KݠE5%gDI*|gdh}u G9iV Z)3M+XS a ]`ՙx4WGY$E{.SS=SKRBQ#$.fpkfMf YR ⎴3W^GWA隼wi^#f4rӏ`l \]uΠD J Vbd {/II$Y3ȠG גO/dv@qCJjj맻9lM\w,W3T~c7jQC{Օb LK#1ҳ vưH؈M1Fu<)I7p60 hH;B5+)t~23 4ђUMp,OHѩK6 [ YyhP)юcLp}eyW:Ҏ6m~ZX td :etTC-U~-ab@N}'Qz~ &w-ZNh,[zXp 3I}fA2'`wnCJMZHØ٪'ZbllG&4ઑh6;k=dKh;zYi[5:v]'l.|o;;W)NA=먤תkRf9Z%\EjĞxCa<]FmUhiڞ.G˖ 1;AaByBB( )G ~ uI:Dד7 F܍Ӥh  ޏU~RTϠG/Lgf8?Rמ Ziy*^I[^6zЍC9Xi"&J/5Қy^m |s[ ޸߿o+U%S;+z _b6;PNS ƭU_}-<I-3щv7+1ںRFssޢbn,)s9-C '4 .ѓYWUn|PBH۟Ӄc0TeN`AC VHp>j|] /+Ưt&jX*"i0dSV0zg8j ߮yiңeӡ=IэN$vEcJϹ pcvĸ( N*-pjغT~+V3u_ܓR2ĕ̲S<۽U3nBu͇O'djTnoٞ`ѱC3~ 9`Y=f´ -\2¤ kX 0z e ~E7DӴmiYPpdvnQq/r j USq8W~:2Oj鎰Nt܌i4׍#OSO*no'F-Fevά~jNx~&h2 ʟi\*Y<2gQlКOF&V`e& kzT 4#WЛEQ,tzvl.-~`qCP>)jv_]҇B1YZ (\X Z Pv^Isgs`9]摡r= ؈& 9Zuft| 2[ۮ>z >׈m6JĞLEGԸV;$3:(Ѱv JZ⾘pEȨH-*Ccs{dΒy(g+^0;>gPKNj!dLudY :p0prl981; }zA>=)Q/(r0h%f1ȰVyGiv<{@۷'l&7`vbݞO en@l$# 7Ő`n 40Ռn!iq1u$q1JG!JNQ7H^ < t~3Ώ#jFZn19P2b6oA1qcBX#Le_bd!U7u{v865 1MQt:ݵ WTAF :mĠcyNE(GҪ]n^i 7I `ZsvDL%@ X)#&),:iFK}2hcb$Z` '2 bVIr'f Q鯦(5Å9ڬck&c{zZbn/vgS mL8l^nvԙE,qQ,JÔJG Xt{[ ֋qtbfzX$p(菃ֺc2'RrT$(ưbDG&ƌ?5,\_z5ZĬ`}}YIh6~iX.dG&]ʳgd Ki?nz0\}JWOCa%>jualiKc_jYEEnEIf(ZX: ?g5\~TGm/Lf=ky>Xw_q4ySp+0* N,z=&LzU=gbèaK=1S}I3@fRny3Iyt=5ҵ DȡtH`jGHwQgsJEX)Q;?=9ҋyunO6LyٙVhi/43i4"z|{uz'a `FPx` @ HSB)mI!u]J*=HVNvW0dA0N>$Zrp-Vw곙?Њ K7\+6C CdPvwҎ3Ek,[;rd"`I3D llbhZjM% )K)K:1LjjL^5,Q]33%s8F~;@5㳙 U%wyO,>2mQsNW3 Xbμ/\ 2$0feڙi8Ylq)}.R=Y7<UϵFH1,ٙ~A˸jqH%~< ֳ85:͍n]VSc1[![;u 2])5ovJJ0 4\`jM{fʼGf1?  B><[9dn [+Bte 7Khgl_.5n[S,%wm#8VSH%>Z/~t]vNwnlBt;CC8֑fFt)\^Ji+ph I6Ud#S$*fLyl1i.˱Vv082Nt.˶PF7XsX(x w򈌴+-x舱QtaRй.< &0Nj*ܒtSEᲭ:p_rJRDBu3ߋ/TC0] ^9;. $#%mŚyB IWeM⾓FਙˀDp4ZI)腊~ @O;;d`e5g"dv MhD |([-P(֦ aa2 jr*bp\W !u6ht{p.!'NY[Kiò Cq;ոQ-"IS뷣I,%)2e <@d+쏗V֛d`q9Oxk7آh, Cbcw8Fhx@s9+Qb_oQ\g xiw&<[wfZq<ǥylK@(}S˽+s V ' 8x&5˗~QPbh( [g4 6gWV8v6_jilKNaRotkZ wہӅ*wm-Gk4$(y\ϓ^L|)id^ ug8 רI%ҰkE3g F'bYYtP  $}d[9LRA+imuIR USclBvYh83 #``*5J͎QT"Aj47#UPBΚ+R`g-(+ LnYzf 2( n.s}XQ9.WTJ2>\ىp4E Vh']Jr˟ dM:H4S\>EIJ6)lw!Ze[&AjeKx̌3 x)pOBbc!훆IDclZMfG2iר2 empδ,ȳ3,MyO$<1-嗝x!Jie\[<"8>rRgRGvvrXmdTtĈLY3 iQF·k,S[u$D?g絗MgԛW Ap0in4 Mk2םyt  uAYAR3Rw0MF06߻ѿEYGb`LC,˯ٮ̾&4&I5VwTi'OhQj1Cz13IH#G%YKJ}q 83b\7'J9斤E!D\`q`R];jFT_Y *"DaKq0Kй99GJFaGpҙ.1R?jG 9qhs3T٨nZA)pTK/f Y {YC*[>`{q.QXu ]Sی8`onj.` K2 UA\h؞pѧˎzC?]c:GU+Qu0r:f]-]>g i%MJnpx3T- n0)eb=\a=MLNd{& s4(H|ijWpKeb(, KXMi.F2A%F%c Ma7 :=W dleqiq̘\ rt&٭,n5inKhPϿGIb s gdP^.޲=MMF`uLx5WD&pȎL,qx\0,":g' 7D*&b299颸 MnUVcX2 b/ )΢3DsųmoLp>rq$~/H~SQ'G> ֛M%:g؋F;h(?J zUvs2 A⃸ xi{ώ-2t 2ïTAO(/UZ)jeOH@}XͣP*egDV&|FV >|yɧD6t &:%g^a#KQL/ʰݥ4( 78]dQ 懛h7@~eBp!1ʎ_ ]߂ZYm}ensb+-&a و6%ˢyI45x.S+䩱PC)QA5R hN- :Ȕ/ HoPvi¼,&޺GIT8J<ՑdGvaGiYSt91Mfe8s@-N@~sQk MІ*[a(lqG\NyN+i4bmE1Va/a4ORn,;i0jOAKljM_w; wƶU{A2Kao/J=w, 9c#@V$mU&}&;W &+|!tW+a.6NhH0ɰJ.oķx}[RڤM;Flې #5lc3)z2F>`Re=KBH1^@5AA>\yF$ )}LVJU_,=#XLGHF˝20,\Bp>h* %JϹ۪Aڬc To7,::dB;Zx2v$n{twug%ںl56T[1­IvjVE1Ȑm(ʾ%O5PZƉ=ë&U轡$H?F<n0PBf'3K _6@kurxzMu9i0>v:1]j;v[nȤiϢnӂ(GBw*B7l@Pdbmٓ,U+I"l!ȅSӐ) ˙(#d^O+Mgx|bdNvbKP쫰)܏0%M-d.4(H=O$5&R+8,nZK#dzYЋno=gR;"a), K*+[Xmb+qzc:uB-]m#sI%pccn5N2thgpQ,\i'~:Us/$9gt k (.mKe`0f.-G@}L{QG鄩)l*עzjw=7͑Ar2bQ_Ѭ<7$wn4^;]h&gD9-`\"]FH_GjWUPLL"A 9~ A[d2|_B> Y~H4U(\N3ڭQz:Ђb52lw#愯WfKTK؅ L`JwHƞߠdvWqǞZgcY!\V}] XthM66.5; Y0, #. f,nbăɰp-HMS qWb-` ^JoXw(ɀ0Ň˿?5 \KVS*R,z{LC#+.dpޔ4x|D,6?fd@ǒ 6ǣUj{gvS;~'L#~ MQŵXx>SuZ\7Φgu:w].N{kwlA?QRqPF5[12 犦=G!:AP*1/ZSWت,b6tEItUJ5/Ӗ0e ~ˊ=h{jfb=rw=V7e<̕dFG_ʻ?.p4JģB*-LE# -mf vxUHϽDRߕQ7ɝ*EDʈ.m [1'{^YssɀW]ǛFvXBl5, g?q!Ǘc(42pj(XC'JEW?;`*Ih9$-̒=ke<\PfvTQ.>U#XBLS@n4D~;H`vٺPW8&BS6 [7X,LNӖFo$U0NJQtUkfUJ;]S޺v?UX(HqtTP@ " `+H!hwSZggZb>Govx.k_'.x&Q!r'>hGajiZbҳH<mA}BP&JiW;x[!m;A~p#&vY|#vەi'l )<6`Un 8huC !7+3[u6cb >hss!&2ں Iaل89.z ƶ 4qZ1oTEtuJr eE+'Er0mXsYOμQߡُߎy0Y6I)kăgLj7 usF]VmD${f^xP=:j.{׈dh.ÍcOxٱIū`6t]a=J,qe:f"}/}ȯ(a Ɖ00R(I:ALx:i <0tu&ӤZMb5Gva7oKy{%1 q,uІ7[~*qlC,K%C)md3伸\XuYb`LVm%vJO• m*Mjd/ `]k8E x[X%cxIm:@M.6e&M_23^2 | b,6fo{v :FזUb: .L-JWbB#YE&%y#4coݍb*zU{4kW1!U1 UـHferd@CЉhXN{ 'Ag[JpF6bbVXN+f̓J5v2I]5qZ9NZ&7V-I8(O{՞FTؕLj[\t lG4uL f Q26qM(x@~0QyY ya|(qݝQ8z-0ՇH$ $~<E;/6csZ:u¹39 3CpGp?#V Ͷl2ϻt4ww*ya(q#M' 3%:U󹟷  ße~.l&f2F00+ .ÁQ8\¹E:yoSVRlIu`h<]l[gm#skSM|F^\VlwPUߵ^D2g*ZӑQA5OI2lt(6RmEݴy0XM0)hh^eS#A_deM0ǒA֑Tq0Yմdf. /8H<S8REJnELrF~( 01kߋKy [F)g+KBbP6h$xՊt-v[enjyxF M ;bfXJEk}gˬAgj9GA~  3taǜ!%i4YȰU|afiұ\N(T{ C6ްiMgMvkfpX`C Ihz(b%LIe &&9U WJgwj΂ iWlhC-p5,#tfzn[DM#lŪ!nr}|_>}pzC;BF =9w]?kX[cVؙ ؕDF@k|:??;z %+7IJg|8YunUZm~3![/cq'eL͡+S;*8Ds#2^Qr(?(R%ڞnu!k ޴H7lis'KTaNt#]#J4Z=G$!sϑd!<ڕm=%>*IcH04v,$KVnKzmDQ3cGJf!^&)bjt!;g+wx?&oRPDzrVFmȄLywj7)ǘ/ R6Q-J ]."\.h$ hK7b[v:\}񅘧?f8^LZivLRMq8^!pT$CDqeDm[$Zh\c;44 wptqx{ daFtT:o>W dnq0n OBcM;荪\"[ċC2987iZDMwtP&/*@MOM¨r.%ce<=z@HEL&&-3/,塦B?JEJt6cOU*~Z\ ;a鋥!y=qDXa"04&IPz# w@YJ|@WC5Z5W /z]c2n ];~khZk}{I1n,9EVq+&Z1WdRGk[ivL?/?6;k~:nXhn686ȧ9Uz4wh61a +5^@KhCd OLeQPDgݿ5ÑҎ Y@S.#j[a3Uo8yҙl4j%u&Ӧӏ]+F#2i4 ڣz|8P$(/m0^fwJfi8n 6Y f1tNc]%qiyM;tbMF}W+k@kr@y3hFw!aIEYm,uFBnvo&l?}^L2k7b VžD=fM FDήybQYzy92Xγf:_)Jr +_ ɚwcDfGO6N!f*}9L˩ƆTE,aO{ҿ,B1ɂ8͑mNuoto&uXE1C]8gybp=N;Y޲k9tLӡ8 ҙ9+^vF5l<}RJ~:CʥLU &M]3N"?KҗHE5lO;AJ5I,, 34!F\h $ޚgࢾ..DejrFqZ׵ev3c{R͈l-/ڱg^]#o'f'rwiÏ P6a0܁ђq]SPv#OE@2pzc$1б2,ȞzuW 'Wi/P$,[vSzc7vWK8vMIf^v %!J=,qB0PCI.5Wͽ!g/c B"0u^x40+Yo:mo5%~ǺL^vjL s% :hff3#$qY]ޝ`k,(\+FE>xM@* -8r"D.{&-79E`~٪ p#M/8/Xgň൦E~< Bqj3jL R=&YMs{, m0? NJ{nǛLph,g6}ӎDac AsOVzleJ'T\:,8̄tkPmx@,Ի#ȼ~{'fM!C,if?p ," sa/w9E&˗[>=FdL~lٙ c;jWa~<'Ka=YN~\PT{{5I2=pgBQ0;%r`SӸs4]z;?jG4cE3NjZ-}[URSYi:oLODyIO) ?q<;`b~cL#iB1*<9I0ic}+#7^ ۩I%Srm0%L*0ZsO_lQ4ZQ$`{j y$Jb9wqZuWgAce0*CCSm%mÓqBis ؗ;n S\ YfaSJ!MgǙJ -jOi"6+ȈO"1`7)I; ` &mB,ZfH,rw"ͮjjVYYtW(jZ|߄Z^ՠ>f1KXLQۘYgrzUb*p7V{ TyvxM^ uϵB%UZQZ]Sّ^!"68?2se#̞IR@ymry~xl+kvS_iqUE ~97KWXn l<)펠Ҧ+w.y4tO'`=eBqɠ١!h ? /l6Σ &cG@W2l#6]:ƚ~BݥB@+}m)5gDqN6TAhvd 6i>/T8}|vm wӊbCuҌV(N¦, 8C;ӫGqe؁%t٨gA-,~b ODˉ3;6eFNGgn7(zڤ3+dcASD, Ep,alUakn4]ĺifpF䷇AG4~*CtMV^(5I# BltuCޤM@zIeiS-fKasRtdhM~`G^92inq-t '-RR&K[~N PF<"#GM92S.d,7#06w۾>ƀu &0^LN[B:f Q#&ɵ LJ5'=*dj͆f>iqRYѰ3{ޢ`+Y^2"k[[aXIx*M-a24*qI<#w9<<RtS7Ժf]K9Z" O% R2UILH, ^AJ>ΥWQk} jt$2I3\M:>E5jddd3_Qm *O[1{Bw}l|?ɮPa"mĐx6! ؅Rsٳa\~UiDNpo5NvIE?WH)WHY{qb#?ː< >vܬ#JX@*%*@7jJ…QHZ%t݂AU3d :Q#XF(OXCuŚEg ^,꜔@Ȣ%*. A'Ja !VϞiVdK%cǙ|Jg7$725r(\5R = fO4+Mu '-.@hɦc1A~a3@Nl4׈miI [(^e{%\u4c& Xv>Ft9V.5R ԋHQCfj2qg6~ ESn!,]z3 mZd쎮ä1.]_+r ;P zęBr4c&x,U$`5ACe|L)FG.V rʪ39YA<'< iD($ḣ(&+6b׵$Yd "䩞_tKR]<9N~p$;K%}W)Oˮfh-t,u'fXW]c=ҹ>MzEc.EI[2@y2O¶$.Qd HuMTfF _YrSwjLΈ [h v23X,i3Tb8yuW+aGV+1{] t.k~5qQGlC/eYl:(6зMDʎd":<~*1 *w;L[P陡bBf $H۪V~r{}G5cF&OøJ^B##^MwhQmOU^ίJۇ\+$,, um=Mե⎦I@e7F2 i$ZcR̨Q)40!1?ElsI43OM @EԜ= tO=AZ;,32ERBn}.TB:T _H|mVƶ[`#?IcV\K xGe4-$ShuÖ,9]O^_gV8Ź<nMhtBFx:i:06"ZY6w#;cyZɩQʣgCWOYXܟHQB N'أehWƹSZ~F W#s1 &tG03aǡ RH^-g%V..!k@]$n5Ӥ;=h9o#dnTg=rJ$w t<:YfhP.Aۚ /W.v+ͦH9!=lV: 6(F/Nۙ\'KUǞuuڌp2 ʪ8.rK#>(LQY)2]qzyW6 ̕ lf$3TvI[yR鮢x=]ԫ_pqFL Usp\s@v򧗏9>ıCj9EF- 2HVU rD+h&6s@\DR?I#O3j8J9qj5֐eR3v2u'_=īPb03];8);X Y8jo [e%bGxaBVV4гi9vy.RUFJ1e<3_5_Pn35pN% K Y]ٶel;OCHnhgxx(6#;m< }21LzxvϭUqTA槯gp*4Zٲ gGŕtj3,{33PRb.6pa]`ՙx4WGYeVzN2`D]#c0+YQqgt#W gT7Αy\ME)J$<vQ`TbU奏@ S%}~se&}UJ2[ jPϧw0Na aFW߿^RUU4sA`а[˕ ,`N쵣2h4)2:3 M8]~nz2N3 B1qc'׃,ÖGs03`4[zQpkL 1/dkȘ$,EuֳCIhh +LL@[7hHۭ(CjTj1PJtVHrfX"9c:XPXʵ`j{d|9n~` c jy䚙3 I˱ NT-NgO*N (3ul/7ˉnc?M I2F՟%P:)LS(3Yu=KRؒ z%z?ŮnZ!5?݂'$­#_vYt$^gV5&ɳe&9pMHA6 B,"ZxYf;+DRv!Ǹc5aniY 8`w؟WݏpK4藿'hC.􂱃]iSɈ|lmT Ϩ.`UvwQH;;B KS*S gFREg2I SvVVݎ9re`"f}_(SDGo=բ8[2Vt4Vm f(G5a kǟ# +\f0>y*M:֔> 턱U+\N-bZh%YHLI5|nJ'rҀn&8*d%Llg;eLbI°$sdCc4 0ZY'i,iaL`Ԟ ӜŤGlih6F$t2!́t>rኑ!+-3Yѱ\cPO%IZ cBb_Phu%*7L6Sa0iBF}3.ʋ,  MLrG1& bG8(׹y2L|??pej+7|79*=^iW$^I6H$H U^\6O'NJgq XX{xFy*$n;V5n5kiFVT~m%r9p} c떚 ab)hsY\K:z&ǹ\c7(/lCL2Q}Sqg+ڄR,H@FGϐYKL\f;+>DiZGe+xxܭbJ6"r/doWa+o6]H`Qqaig ;pˤ3p:bqΗ\DUw*[=B`>٦xCDmG%IG>E̟gŻg7WaheldW}Zd#$k*3srk}[?? *Q!KĭAl =47Ђ=r.&+5ϒ,` UgZ2z/1~{2(D@[>Ҵ'U:k(tHD"s@Y gwq NQm6 L2&A1?0[Uׂ^E AfA3nc:.5W b`Jb='BOca8}]vp(c&q3$Uo>^xMK#Z }O ;񇣟?{c!לAɴy:㣑7"r(ûaluX_J%k/ozU$Qg3(ư.KOD/ `b3%S)DFRn Ъ/̞qV}Ml¹JWG,eu՜rEXVrEq;SyvXU8j FWAG`SK|K 9h5-i=N2p4groMOxq֑yEp1@G6ֈeQmLOΎ0K1(_UGCKXD2}+ni3[W JsvIQRz6OZzƻ,x[Got9]Z):ʖӋMc3{oAԉ u;ä $S=!G!-rTeڔ:%*&ڜV\&WI%uCggyi]EMJG]z=rJT- bu+lS=- B0krxхpY!Nt5el*;|KdA>I Ő?K|pį4v+LYseZRڥei뗵6<LA\@1Q"<CL#|_+@FlW#J, ༘IN4<j+rY0+CN],Xy{T%ȳzK,CWsD KY!% hpcǐaG_p b_w.)O4Yi̾~eB_K[D@K8SA_O}!=@UwcѰ"hET({\DNO2: OϿ3.Nsbm::|:$|-9mL~f 9R]7rNnI+9 (C4ue㲙;=`-. DAgy裉nɀb_(;lCG&ƣi攣d  o }MxrrYEjXVbfN,qEd9ղ&iEy:dWRڿxXbBL|{@&)-#ϴ3*V:aa^ T$ _*b@8rŖ@v:G3f,O PNmt:fCW a|+^ c]=^k10LbX'_D'{ö {rsʜ0✚q :+(߾(5Acl:5FNlx1};Q%Rbvo>VPYBWFWi k*z7lMN63sjpd)p]sШ)ˢ?yl4? Q7k b g>U5M:#?qWWp1R,(Ǭ>3LS;r`V~c)qU: 6}i}-;f QVE(ULUxqƏT026( j uвj|e/ZJ@?m4L lI ?,}p56+g D-[fJw SB_MJMaUs9Aܿ0;Vyi<`x_oE+oknuN Q!&>64HdMYU~d&aif݇IqK?Rwb>Qp҃PM;/wij)@#Mۄul)"lw#@-Y?do~ҩi&#j鷷@̈/ӶEw@@\-)N-ԼtNƵ ͼ#C"$-pCwg L9&^5BA8kI[h Ѵzy[^9HAyh 8[ n 3``AD$%E]F gfdxO<@vp Wk2 &h0qCTO%4A9p6m{*/h9Ǥ/yM ]@#ЈtbvOO_0OjW`@TRc0ŏ-Ufˈ>N@-wUf7aX/بbϟ]]IW>! jvvv?}?#]O'@o{son2G7nM~ >ˉ-Z鰝AWO-mǎwп S a*v:gN8DQi`Տ}]L*z\Bw*fᷧKbxeo^LOKnC#۠*+*!z(qN88L8.bA_"9wm7֤p8;2$=]npTi ^FLrŖPIv\(0C ãD"s(gjhgDz3Brc|ؐOZ*Cqd{L<}*\50TTa)6:q#\D sل_41]rX'#i&DӺɍ%-HdUO0ueejUF8Xjg}Kzh/:JP{ejoȝbcG.T˪ }KχSĉ<ʣܩV-C  P|(R}F>w87e|},AS#iKF6^5aiZf;&U)1a r(DwӍ9{!M i;g@ E?}c n?PLaNX%8mq$mQ$ ykX"+} !yrq]ߚj-}ޗf$NQ(yv_sBe8ۼԦ~m#1Guu@ %e]W[%Foâ}/@%: 0'ٸ6?4Ym}T@BQ!m_~/?H1mH~oCϏ/sa߾O6!Gj=BQ)wf<^5-Fe^,F4,xOR?Z>{9]h07*|i ߶7DfOkĵnc6r:~:G/z=[;߳{\gVio\ЮRWvk.Io e "Lcl{u%1L twV#`zOy뒎9狷mN\Q :2k qo|Dpc՚1\u'A־m3JZ3>7u-6B6Z VE{ѣ 6h_Nd{Bfqa[ qDE^ՒZ%~uk}W7m꬞X#%J\+dѴĉ ml e\PӺZVq+N;8GMN/v\Kvȓw"#*U?yqqU^]bTT+vyҵUxYN.PLlS**DTyN?p]RW*FxSu<}b}lb{"u V-C"{a8,~ MOMĄAx^1( p@,1`!UhZh)z(+4/ QpOf0"hh>qhhI~s x 8W"0Eàd"ZjCJ:0$!e+W}l. /Wxp,W.tZrH?oڿ1y/ȣQW}kނcpIeWIg>5$&#͔YF+5d Ak1jp.Y]FcP= *Gv־ ї' D9\A=EڒvzxN1 E]n}wH *vɲ8d Ssv\W3O|}U2]M²}0a(w.ԂFT1ee_|KQ>SB Un/ֿK4[%X3D `A{AT!n@#`''g_ei*X[L@}7ume3/2Nm#<ֻҺYt 84.p|y96.eK`0H-=q贙M/_j8[_eRQ4sdqBFۯza|!ɟ{kۃVuQ,˸]B"__^7I<%8dM.%cЄNM@{dbYNΉ= BxZq"(58+ОDZ`fS懑Aybrıf ZCUⰑM1v7~}E"4~IpמˈjevN CZ ћFDH| h(>WkE3fOvR&wF,w*HkH0݁󑖵y/׹/ziUQ `oetXaoSG`8]%p(%qa8LM–U7U:O{S|@*Tupg4 JJ`a>k`<s篂UbTUX?v1a>֧t[RDobO6sh;˪փSX cApx玏ީO\u1<+bj*@D1~ćb<ϰN1A8O8TBT Dȕlب'.,&?cK YR8< MM%A^AF!z>X{.܆YD,m4xǵʄ  ,-٣"ԜnDQvpR>VIJp۔%2cX0m@֑=4v^ۑe`Pb76= w 0-hqB$Y=cK+fl@r$L`-h@'}o~_M_0:j^G>OFpУT 6IBad縦۠^+*xNrC%L Rz腡G -duʼ{c] eq+n#~-/YE8듛3ߵ;w Ew$B*a}o[SV SVxRnʙyO|$;YZ(}@:knܰH.7c>[yx%WT >h.1?;lT6KI@<R r_q`v/x[7HA piʼv4" q=M7 C֔I/ ҕ@,m2t v[GM2$i/w0ٸ|rY^3z_ܐ]FTЌzFwr$}Qd%fj%6+cbك;PqSPN-lknZZ0Z vIWD ݆uH:n8}i徆f t4((u1{Me&l6~R~%ݓOZZ^)|wDfq`f0[Յ˫HuzA$*FԲ>QG`d>>YX52P ( Pҗ4SI0yL>Y6S Sbct:Q} ߄;}|YsM e uoi\m]R$|6Շ >1ַy_kpvz2%&Iz0_~O?__~& WjP0$ 6Tyv}i^d6 ;0[NG6Yp aKղ Ƿ6Ѿvw24gT$ 鈐s9!]⃘t2(Nճ940 9qc>Pq-nB0~QYD$i-Ί|$exB@,k"w0UFM&{){#0 ur܌}0F-ĢMHšs=/2),BxK=]B$}4"6dy^h(f9]r>si' ]9i9=Px4}r4J~}w*ԽrObeyluI q ,n ~dnDq`ȼp%M5Ih *{yzm'}t@`]:PIe|aKH; 'ԉyb?1;V]1+I|YJ #fIq8,*Ֆ'8!f֢Z+umR0GQ81Ytb!2EӲ̵{^ǎųׅ=R@br@!e$owlw"'x'F4e؆_] X??aaq\elCda$UE\ɶKꁷsOfmC{_GUV$A}[F n}{Z[\UO s1/2,~AEvRYl-[HzY.-dY+a7~QDbosYw%V;L/xZ8  ? PYŃ.=&0 Uncategorized – Penloom https://penloom.com News articles and more Fri, 05 Sep 2025 22:27:18 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.2 https://penloom.com/wp-content/uploads/2022/01/cropped-favicon-32x32.png Uncategorized – Penloom https://penloom.com 32 32 Ozempic for Weight Loss: The Celebrity Trend Sparking Debate https://penloom.com/ozempic-for-weight-loss-the-celebrity-trend-sparking-debate/ https://penloom.com/ozempic-for-weight-loss-the-celebrity-trend-sparking-debate/#respond Fri, 05 Sep 2025 20:56:56 +0000 https://penloom.com/?p=16315 Are you following celebrity lifestyle, or love to see them off-screen on social media? Well, yes, then you obviously noticed one thing about some celebrities. The actor who looked bulky a few months ago now looks like he or she has undergone a huge weight loss.

The list of those who have lost weight in a very short period of time is very long, including Dave Bautista, Khloé Kardashian, Amy Schumer, and Jessica Simpson. Bollywood celebs also did the same short weight loss journey for their weight loss. Ram Kapoor, Karan Johar, Bhumi Pednekar, and Kusha Kapila are a few Bollywood celebrities who have undergone sudden weight loss.

How do you think these celebs lost weight suddenly? Well, according to these celebs, they follow a strict diet plan and do weight-loss exercises. But there is one drug name that is rumored for its weight loss, Ozempic. In this blog, we gonna talk about it more, so let’s jump into the discussion.

What is Ozempic, and how did it come into the spotlight?

Ozempic, also known as Semaglutide, is a drug that is mainly used for the treatment of type 2 diabetes. This drug came into the market in 2017 with FDA approval. It was specifically approved as an injection given once a week. The approval given to Novo Nordisk was for Semaglutide under the brand name Ozempic for the treatment of type 2 diabetes. Later, it was found that it also helps with obesity.

Some drugs, originally approved for specific conditions, are now being repurposed for entirely different uses. Aspirin was originally used to relieve pain and reduce fever. But now, it is also used to prevent heart attacks and strokes by thinning the blood. Minoxidil was originally used to treat high blood pressure. It is also used for treating hair loss (sold as Rogaine). The same case happened with Ozempic.

This drug came into the news in August 2023 when there was a shortage of it in the drug market due to its huge demand. Due to this sensational news, many celebrities refused to use it. Ozempic’s drugmaker, Novo Nordisk, emphasizes its use in treating type 2 diabetes, improving blood sugar, and reducing cardiovascular risk in adults with the disease. Despite this, the popularity of Ozempic for weight loss has grown among both celebrities and the general public.

Is Ozempic clinically safe for weight loss?

Ozempic, though effective for weight loss, was never officially approved for it. The FDA cleared it solely for managing type 2 diabetes, helping control blood sugar, and lowering cardiovascular risks. But its side effect of suppressing appetite led to off-label use for shedding pounds, sparking debates on safety and ethics.

This is why many celebrities and influencers may deny its use. Also, doctors warn that Ozempic isn’t a magic solution for weight loss. On the other hand, clinical trials support their weight-loss benefits, but these studies primarily involved diabetic patients or those with obesity-related conditions. For healthy individuals, the long-term effects remain unclear, with risks like nausea, pancreatitis, and even muscle loss.

One major concern is side effects. Users commonly report nausea, vomiting, and diarrhea, but more severe risks like pancreatitis, gallbladder issues, and even potential thyroid tumors (seen in animal studies) raise red flags. Then there’s the dreaded “Ozempic face,” sudden weight loss that leads to loose skin and a gaunt face, a loss many people don’t expect.

The Ethical Debate: Should Ozempic Be Used for Cosmetic Weight Loss?

The growing trend of using Ozempic for quick weight loss has sparked serious ethical concerns. Originally meant for diabetics, the drug’s off-label use by celebrities and non-obese individuals has led to shortages, leaving those who genuinely need it struggling to access medication. Doctors argue that prioritizing cosmetic weight loss over medical necessity is irresponsible, especially when safer, long-term solutions like diet and exercise exist.

Another issue is the lack of long-term safety data for healthy individuals. While Ozempic helps diabetics and obese patients, its effects on people without these conditions remain uncertain. Severe side effects like pancreatitis and thyroid risks raise questions about whether temporary weight loss justifies potential harm. Additionally, the rise of “Ozempic face” (sagging skin due to rapid fat loss) shows that even desired results can come with unintended consequences.

Beyond health risks, the trend promotes unrealistic body standards. When celebrities credit “hard work” for their sudden weight loss, while likely using Ozempic, it fuels unhealthy comparisons. Normalizing prescription drugs for cosmetic purposes sends a dangerous message: that quick fixes are better than sustainable lifestyle changes. The debate isn’t just about a drug; it’s about how society values health over appearance.

The Future of Ozempic: Medical Breakthrough or Dangerous Trend?

Ozempic’s rapid rise from diabetes treatment to celebrity weight-loss secret has left everyone wondering: where does it go from here? The drug’s ability to help people shed pounds quickly is undeniable, but its long-term role in medicine remains unclear. Will it stay focused on treating diabetes, or will it become the next big thing in the weight-loss industry? The answer isn’t simple because the stakes are high on both sides.

On the one hand, the Ozempics represent a major scientific achievement. For diabetics and those with obesity-related health risks, it’s more than just a quick fix; it’s a lifeline. Studies show it can significantly lower blood sugar and reduce heart disease risks, benefits that go far beyond weight loss. If used responsibly, it could improve countless lives. But on the other hand, its popularity as a shortcut for cosmetic weight loss raises serious concerns.

The biggest question is whether Ozempic will follow the path of other repurposed drugs like Botox, which went from medical use to a beauty staple, or if backlash over shortages and side effects will limit its reach. And with social media fueling demand, regulators may step in to control how it’s prescribed.

Final Thought

Ozempic’s weight-loss effects are undeniable, but its off-label use raises serious medical and ethical questions. While it helps diabetics and obese patients, healthy individuals risk side effects for cosmetic benefits. Sustainable lifestyle changes remain the safest path. As the debate continues, one thing is clear: quick fixes often come with hidden costs.

]]>
https://penloom.com/ozempic-for-weight-loss-the-celebrity-trend-sparking-debate/feed/ 0